We explored the binding of octamer
Introduction
HIV-1, the cause of AIDS, still remains a leading cause of morbidity and mortality worldwide. Because of its facile ability to mutate in response to anti-retroviral therapy, the virus remains a formidable foe. Some regions of the HIV-1 genome, however, are less likely to mutate without significantly disrupting the viral life cycle. The HIV-1 transcriptional promoter/long terminal repeat (LTR) is one such region, particularly the proximal transcription factor binding sites. As a true parasite, the integrated HIV-1 provirus is dependent on the binding of host cellular transcription factors to a variety of DNA sequences located within the LTR of the viral genome for efficient replication (Al-Harthi and Roebuck, 1998; Cullen and Greene, 1989; Greene, 1990) .
Much progress has been made during the past decade and a half in terms of defining cellular transcription factors, such as stimulating protein 1 (SP1), nuclear factor nB (NF-nB), and nuclear factor of activated T-cells (NFAT) , that bind within the proximal LTR immediately upstream of the transcription start site (TSS). These cellular factors play essential roles in stimulating the activity of the HIV-LTR in response to a variety of cellular stimuli (Cron et al., 2000; Harrich et al., 1989; Nabel and Baltimore, 1987) . Nevertheless, there is still much to be learned about host cell transcription factors that regulate HIV-1 transcription, including those that bind within an upstream region of the LTR called the negative regulatory element (NRE). The NRE was so named because it has been shown to reduce the activity of the HIV-1 LTR (Siekevitz et al., 1987) .
Based on weak homology to the consensus octamer transcription factor (Oct) binding motif, 5V ATGCAAAT 3V (Falkner and Zachau, 1984; Parslow et al., 1984) , Liu and Latchman (1997) identified four potential Oct binding sites within the HIV-1 LTR. Three of these sites are located within or nearby the NRE, and the fourth is situated immediately upstream of the TSS (Fig. 1) . They further reported that overexpression of either Oct-1 or Oct-2 in a fibroblast cell line markedly inhibited HIV-1 LTR transcriptional activity and its transactivation by Tat protein (Liu and Latchman, 1997) . Although Oct-1 is constitutively expressed in most cell types, Oct-2 expression is largely restricted to lymphocytes. In T cells, Oct-1 and Oct-2 have been shown to positively regulate interleukin-2 (IL-2) gene activity by binding to two cis-elements within the proximal IL-2 promoter Kamps et al., 1990) . In addition to acting as positive regulators of transcription, however, Oct proteins have also been shown to inhibit transcription of a variety of genes (Wysocka and Herr, 2003) . One example of this is the ability of Oct-1 and Oct-2 to inhibit IL-4 promoter activity in primary human CD4 T cells by blocking the binding of NFAT transcriptional activators to two surrounding NFAT binding sequences in the proximal IL-4 promoter ). Thus, Oct proteins could theoretically be manipulated to inhibit HIV-1 transcription in lymphocytes.
Unlike fibroblasts, CD4 T cells represent a primary cell type infected by HIV-1. Therefore, to assess the ability of Oct-1 and Oct-2 to be employed as realistic inhibitors of HIV-1, we explored the role of Oct proteins in HIV-1 transcription in primary human CD4 T cells. In this study, we investigated the capacities of Oct-1 and Oct-2 to bind the HIV-1 LTR in vitro. In addition, we analyzed the effect of Oct-1 and Oct-2 overexpression in primary human CD4 T cells on HIV-1 transcription and on virus production in HIV-1-infected cells. Our results demonstrate that Oct-1 and Oct-2 fail to bind to the HIV-1 LTR, and overexpression of Oct proteins has no effect on HIV-1 transcription or replication in primary human CD4 T cells.
Results
Oct-1 and Oct-2 do not bind to the four putative sites within the HIV-1 LTR Although Liu and Latchman (1997) previously identified four potential Oct binding sites within the HIV-1 LTR, no binding studies were performed. We initially assessed binding by using nuclear extracts from BJA/B cells because they are a rich source of Oct-1 and Oct-2 transcription factors. By electrophoretic mobility shift assay (EMSA), factors from this extract clearly showed the ability to bind an oligonucleotide probe containing the Oct consensus binding sequence derived from the human immunoglobulin kappa chain promoter (Fig. 2, lane 1) . Two bands were revealed and were shown to be specific by inhibition with excess cold (unlabeled) self-competitor (lane 2). The upper band was supershifted to the top of the gel with an anti-Oct-1 antibody (lane 3), and the lower band was supershifted with an anti-Oct-2 antibody, demonstrating the specificities of these two bands. However, this same nuclear extract failed to bind to any of the four putative Oct binding sites from the HIV-1 LTR (Fig. 2, lanes 5-8) . Similar results were obtained using nuclear extracts from activated primary human CD4 T cells (data not shown). These results demonstrate that neither Oct-1 nor Oct-2 is capable of binding in vitro to any of the four previously identified putative Oct binding sites within the HIV-1 LTR. This is not entirely surprising because none of the four sites share more than six of the eight consensus base pairs and two of the sites lack the critical ATG motif.
Oct-1 and Oct-2 have no effect on HIV-1 transcription in primary human CD4 T cells Previously, Liu and Latchman (1997) demonstrated that overexpression of Oct-1 or Oct-2 markedly inhibited basal HIV-1 LTR-directed transcriptional activity in a fibroblast cell line. Although we were unable to detect Oct binding to the HIV-1 LTR in vitro, it remained possible that overexpression of Oct proteins would still be able to alter HIV-1 transcription through an indirect mechanism(s). To determine the roles of Oct-1 and Oct-2 on HIV-1 LTR promoter activity in primary CD4 T cells, freshly isolated human peripheral blood CD4 T cells were transiently co-transfected with pLTR-Luc (reporter plasmid) plus pCG (control), pCGOct-1, or pCG-Oct-2 expression constructs by our own established methodology (Cron et al., 1997) . After 2 h of rest, the cells were polyclonally activated for 6 h and analyzed for luciferase activity. Compared with the empty vector control (pCG), overexpression of Oct-1 or Oct-2 showed no significant effect on HIV-1 LTR-driven transcription in primary CD4 T cells (Fig. 3) . Similar results were obtained without activation (data not shown). Because Liu and Latchman (1997) had also previously shown that Oct inhibited transactivation of the HIV-1 LTR by the HIV-1 Fig. 1 . Potential octamer binding sites within the HIV-1 LTR. The four potential octamer binding sites (OCT) are noted. Numbering below the bar is relative to the transcription start site nucleotide (+1). Abbreviations: NFAT, nuclear factor of activated T cells; NFnB, nuclear factor kappa B; NRE, negative regulatory element; SP1, stimulating protein 1; TAR, transactivating region; TSS, transcription start site. For the four putative OCT sites in the HIV-1 LTR, the following oligonucleotides (including the Oct consensus oligonucleotide) were used during EMSA in these studies: site 1 (À369 to À376 bp of non-coding strand) 5VGTGTAGTTCTGCTAATCAGGGA3V; site 2 (À232 to À226 bp of coding strand) 5VAGCCTGCATGGGATGGATGACC3V; site 3 (À168 to À174 bp of noncoding strand) 5VGGCCACGTGATGAAAT GCTAGG3V; site 4 (À7 to À14 bp of non-coding strand) 5VCCAGTACAGGCAAAAAGCAGCT3V; and Oct consensus (human immunoglobulin kappa promoter; Staudt et al., 1986) 5VTGAGGGTATGCAAATTATTAAG3V. The core Oct sequence residues are italicized and the identical residues in the HIV-1 LTR sites are underlined.
Tat protein, primary CD4 T cells were co-transfected with the HIV-1 LTR reporter gene along with a Tat expression vector and pCG, pCG-Oct-1, or pCG-Oct-2. As expected, Tat expression augmented HIV-1 LTR transcriptional activity (an average of 4-fold, n = 2), but the presence of either Oct-1 or Oct-2 substantially increased HIV-1 LTR reporter activity by an average of 18-and 9-fold, respectively (n = 2). These results are in stark contrast to those of Liu and Latchman (1997) who showed that Oct inhibited HIV-1 LTR activity as well as Tat-mediated transactivation of the HIV-1 LTR in a fibroblast cell line.
Oct-1 and Oct-2 have no effect on HIV-1 infection in primary human CD4 T cells
To exclude the possibility that Oct proteins inhibit HIV-1 LTR activity in CD4 T cells via interaction with Tat or any other HIV-1 accessory proteins, primary human peripheral blood CD4 T cells were infected with HIV-1 in vitro. First, to overexpress Oct proteins in a large percentage of primary T cells, we employed a novel electroporation-based technology (Amaxa) that consistently transfects 50 -80% of freshly isolated human peripheral blood CD4 T cells in our hands (Cron, 2003) . Protein expression derived from transfected plasmids can also be detected up to a week postelectroporation (Cron, 2003) . Using this approach, primary CD4 T cells were co-transfected with pEGFP-N1 and pCG, pCG-Oct-1, or pCG-Oct-2. The cells were then polyclonally stimulated for 2 days to allow for HIV-1 infection. The CD4 T cells were then infected with the NL4-3 strain of HIV-1 and analyzed 3 days postinfection.
After 3 days of HIV-1 infection and 5 days post-transfection with the Oct expression plasmids, the CD4 T cells were analyzed for productive HIV-1 infection. First, overexpression of Oct-1 and Oct-2 was confirmed at the protein level by EMSA. Nuclear extracts were generated from polyclonally activated CD4 T cells 2 days post-transfection at the time of HIV-1 infection and 5 days post-transfection at the time of HIV-1 infection analyses. The extracts were analyzed for binding to an Oct consensus probe and nuclear extracts from BJA/B cells were used as migration references for Oct-1 and Oct-2 (Fig. 4, lane 1) . Both the TE (lane 2) and pCG (lane 3) control transfections revealed proteins migrating identically to those from BJA/B cells. Unlike BJA/B cells, in which there appears to be roughly equivalent expression of Oct-1 and Oct-2, Oct-1 expression is greater than Oct-2 in primary human CD4 T cells. In addition, a faint and faster migrating band was also seen in CD4 T cells (lanes 2 -5). This is consistent with the fact that lymphocytes express two isoforms of Oct-2, Oct-2A, and Oct-2B (Schreiber et al., 1989) . Overexpression of Oct-1 revealed significantly increased binding of the uppermost band (lane 4), but not the lower Oct-2 bands, whereas overexpression of Oct-2 showed increased binding of Oct-2B only (consistent with the cDNA present in pCG-Oct-2). Similar, but less dramatic, results were seen at 5 days posttransfection (lanes 6-9). Therefore, overexpression of Oct proteins achieved by Amaxa electroporation led to significant increases in the specific Oct proteins transfected, and the increased levels were present at the time of infection and throughout the period of infection.
To analyze the effect of Oct overexpression on virus production, p24 expression was analyzed. Specifically, 2 days after infection with HIV-1, the media were exchanged with fresh media, and 24 h later the media were analyzed lanes 4 and 8) , pCG-Oct-2 (lanes 5 and 9), pCG (vector control, lanes 3 and 7), or TE (buffer control, lanes 2 and 6). Nuclear extracts were prepared from transfected CD4 T cells at day 2 (lanes 2 -5) and day 5 (lanes 6 -9) after transfection and were analyzed for Oct expression by EMSA using the Oct consensus probe as in 5 . Overexpression of Oct proteins has no effect on p24 production by HIV-1-infected CD4 T cells. Freshly isolated primary human CD4 T cells were co-transfected with pCG-Oct-1, pCG-Oct-2, or control plasmid (pCG) plus a GFP marker plasmid (pEGFP-N1). The transfected T cells were activated polyclonally with PHA (2 Ag/ml) and rhIL-2 (20 IU/ml) for 48 h and then infected with the NL4-3 strain of HIV-1. The culture media were exchanged with fresh media at day 2 postinfection, and 24 h later supernatants were harvested. p24/gag levels were detected in the supernatants by ELISA. One representative experiment of six is shown.
for p24/gag expression by ELISA. As shown in Fig. 5 , overexpression of Oct-1 or Oct-2 had no significant effect on p24 recovered in the supernatant compared with the control expression vector. Thus, unlike overexpression of other transcription factors, which can significantly alter p24 expression of HIV-1 virions or proviruses (Cron et al., 2000) (and data not shown), overexpression of the Oct proteins did not alter HIV-1 infection of primary CD4 T cells.
Another measure of HIV-1 infection of CD4 T cells is apoptosis, which occurs in both infected and bystander CD4 T cells during HIV-1 infection (Selliah and Finkel, 2001a) . To address whether overexpression of Oct proteins modified HIV-1 enough to alter apoptosis, primary human CD4 T cells were transfected with the Oct expression plasmids together with a green fluorescent protein (GFP) expression plasmid. As above, the transfected cells were polyclonally stimulated for 2 days in vitro and then infected with the NL4-3 strain of HIV-1 for an additional 3 days. Apoptosis of the CD4 T cells was assayed by flow cytometry; apoptotic cells were identified by staining with Annexin V and 7AAD. GFP fluorescence was used as a marker of Oct-transfected cells because we have previously demonstrated by fluorescence microscopy the coordinate transfection of two different fluorescent labeled plasmids by the Amaxa transfection methodology (M.Z. and R.Q.C., unpublished data) as well as by our own transfection protocol (Cron et al., 1997) . As seen in Fig. 6 , after 3 days of HIV-1 infection, there was little difference in levels of apoptosis among infected (p24 + ) or bystander (p24 À ) CD4 T cells, whether they were transfected with Oct-expressing plasmids (GFP + ) or not (GFP À and pCG control transfected). On average, from a total of six experiments, there was no consistent difference in levels of apoptosis detected in HIV-1-infected and bystander T cells comparing cells overexpressing either Oct-1 or Oct-2 relative to controls. Moreover, in each sample, the percentages of GFP + cells were similar among cells transfected with pCG (control), pCG-Oct-1, or pCG-Oct-2. Lastly, the p24 + percentages were comparable in the pCG (control), pCG-Oct-1, and pCG-Oct-2 groups (data not shown), confirming the results in Fig. 5 . Thus, analysis of apoptosis among HIV-1-infected and bystander CD4 T cells confirmed the p24 analyses showing that overexpression of Oct proteins in primary human CD4 T cells has little to no effect on HIV-1 infection. Fig. 6 . Overexpression of Oct proteins has no effect on apoptosis of HIV-1-infected and bystander CD4 T cells. Freshly isolated human peripheral blood CD4 T cells were mock transfected with TE (diluent control) or co-transfected with pCG-Oct-1, pCG-Oct-2, or control plasmid (pCG) plus a GFP marker plasmid (pEGFP-N1). The transfected T cells were activated and then infected with the NL4-3 strain of HIV-1 as in Fig. 5 
Discussion
In this study, we have explored the ability of Oct-1 and Oct-2 proteins to regulate HIV-1 transcription in primary human CD4 T cells. We hypothesized that Oct proteins might repress HIV-1 replication in primary human CD4 T cells for the following reasons. First of all, overexpression of either Oct-1 or Oct-2 in HeLa cells or BHK cells dramatically repressed both the basal activity of the HIV-1 LTR and its transactivation by Tat (Liu and Latchman, 1997) . Next, both Oct-1 and Oct-2 are capable of augmenting the T cell-derived cytokine IL-2 Kamps et al., 1990) . The ability of Oct proteins to augment IL-2 production might be of benefit to the infected host because HIV-1 leads to the progressive loss of CD4 T cells and IL-2 may facilitate their recovery (Katlama et al., 2002; Levy et al., 2003) . Moreover, Oct proteins' capacity to inhibit IL-4 transcription Wysocka and Herr, 2003) suggested that they are candidates to promote a Th1 rather than a Th2 pattern of cytokine gene expression in activated CD4 T cells. This might also counter HIV-1 infection because the virus replicates more efficiently in Th2 cells (Mwinzi et al., 2001 ) and progressive decline in HIV-1-infected individuals has been shown to correlate with a loss of Th1 function (Clerici et al., 1993) , important for the elimination of intracellular pathogens. Therefore, overexpression of Oct proteins might inhibit HIV-1 transcription and replication.
From our study, however, overexpression of Oct-1 or Oct-2 alone had no effect on HIV-1 LTR reporter gene activity in primary human CD4 T cells (Fig. 3) . This was not due to the inability of this reporter gene to be affected by overexpression of transcription factors by transient transfection in primary human CD4 T cells because we have previously demonstrated the ability of NFAT transcription factors to markedly augment HIV-1 LTR activity under identical conditions (Cron et al., 2000) . Nor was the lack of effect of Oct proteins on HIV-1 transcription due to the Oct expression plasmids employed in these studies because the identical plasmids either augmented or inhibited IL-2 or IL-4 transcription, respectively, under the same circumstances . This is also not entirely surprising because Oct proteins are incapable of binding to any of the previously identified putative Oct binding sites within the HIV-1 LTR (Fig. 2) . Lastly, overexpression of Oct-2 along with its co-factor, OCA-B, did not change HIV-1 LTR activity in primary CD4 T cells compared to overexpression of Oct-2 plus the control vector for OCA-B (data not shown). These studies, however, were all conducted in vitro, and it remained possible that Oct proteins could alter HIV-1 during infection.
Until very recently, it has been difficult to overexpress proteins of interest in primary human CD4 T cells. One approach has been to introduce genes using retroviruses (Curran et al., 2000) . However, this approach is less than ideal when studying retroviruses themselves, such as HIV-1.
In this study, we have taken advantage of a novel commercially available electroporation technique which allows for efficient introduction of plasmid DNA into primary human CD4 T cells (Cron, 2003) . Because expression of the plasmid DNA persists for up to a week post-transfection (Cron, 2003) , we have been able to develop a protocol that not only permits overexpression of a gene(s) of interest but also allows for HIV-1 infection of the same population of primary CD4 T cells (see Materials and methods). With this approach, we established that Oct overexpression had little to no effect on HIV-1 infection in primary human CD4 T cells as detected by p24 expression and by analysis of apoptosis of infected and bystander CD4 T cells (Figs. 5  and 6 ). It is possible that overexpression of Oct is not detectable until 4 days postinfection, but overexpression of other transcription factors in primary human CD4 T cells has demonstrated effects on HIV-1 expression within this time frame (Cron et al., 2000) (and data not shown). Because these were essentially negative results, we went on to demonstrate that the Oct proteins from transfected plasmids were indeed overexpressed at the protein level, and in addition, were capable of binding to DNA (Fig. 3) . It is therefore very likely that overexpression of Oct transcription factors has little to no effect on HIV-1 transcription in primary human CD4 T cells, at least within the first 3 days of infection.
These studies demonstrate the importance of analyzing HIV-1 transcription in cell types that are actually infected by HIV-1. Moreover, because primary cells differ in many respects from cell lines and tumors (Cron et al., 1997; Hughes and Pober, 1996) , it is important to study HIV-1 infection in primary human CD4 T cells. Lastly, although we were unable to demonstrate a role for Oct overexpression in primary CD4 T cells, Moriuchi and Moriuchi (2001) have reported that overexpression of Oct-2 or octamer coactivator BOB.1/OBF/OCA-B can increase the expression of CCR5, a major co-receptor for macrophage-tropic HIV-1, and the fusogenicity of the cells with R5 HIV-1 Envelope. Thus, further exploration of the role of Oct transcription factors during HIV-1 infection may be warranted.
Materials and methods

Plasmids and reagents
The expression vectors pCG-Oct-1, pCG-Oct-2, and pCG (the parent control) were generously provided by Dr. Winship Herr (Cold Spring Harbor, NY) (Tanaka and Herr, 1990) . The Tat expression vector pSV-Tat72 and control vector pSV2-neo were kindly provided by Dr. Dennis Kolson (University of Pennsylvania, Philadelphia, PA) (Kolson et al., 1994) , and the OCA-B/OBF/BOB.1 and control [pcDNA3.1(À)] expression vectors were kindly provided by Dr. Robert Roeder (Rockefeller University, New York, NY) (Luo et al., 1992) . The green fluorescent protein (GFP) expression plasmid pEGFP-N1 was purchased from Clontech (Palo Alto, CA). The pLTR-Luc reporter construct generated by subcloning the 3V HIV-1 LTR segment into the polylinker of the promoterless pGL2-Basic firefly luciferase reporter gene (Promega, Madison, WI) has been previously reported (Klebanoff et al., 1994) . The Renilla luciferase-expressing transfection control plasmid pRL-null was obtained from Promega. The lectin phytohemagglutinin (PHA), the phorbol ester phorbol myristate acetate (PMA), the calcium ionophore ionomycin, and 7-aminoactinomycin D (7AAD) were obtained from Sigma (St. Louis, MO). Anti-Oct-1 and anti-Oct-2 antibodies were acquired from Santa Cruz Biotechnology (Santa Cruz, CA). Phycoerythrin-conjugated anti-HIV-1 core antigen (p24) antibody, the ELISA kit for HIV-1 p24 Ag detection, and Annexin V staining reagents were products of Beckman Coulter (Miami, FL). Recombinant human IL-2 was obtained freely from the NIH AIDS Research and Reference Reagent Program. HIV-1 molecular clone NL4-3 was kindly provided by Dr. Terri H. Finkel (The Children's Hospital of Philadelphia, PA).
CD4 cell isolation
Adult human CD4 T cells were isolated from the peripheral blood of healthy adult volunteers by negative selection using a proprietary antibody mix (StemCell Technologies, Vancouver, BC) and red blood cell rosetting as previously described (Cron, 2001; Lansdorp and Thomas, 1990) . In brief, freshly isolated human peripheral blood was incubated with CD4 T cell enrichment cocktail (monoclonal antibodies to CD8, CD16, CD19, CD36, and CD56) and incubated for 20 min at room temperature. The sample was then diluted with PBS, layered onto a Ficoll-hypaque gradient, and centrifuged for target cell enrichment. CD4 T cell purity ranged from 90% to 97% as detected by flow cytometry (data not shown).
Transient transfection luciferase reporter assays
Primary human peripheral blood CD4 T cells were transiently co-transfected with pLTR-Luc (5 Ag/5 million cells), pRL-null (1 Ag), and pCG (control), pCG-Oct-1, or pCG-Oct-2 (10 Ag) by electroporation as described elsewhere (Cron et al., 1997) . In Tat-mediated HIV-1 LTRluciferase reporter assays, the Tat expression plasmid (10 Ag) or its empty control vector was co-transfected as a third plasmid. The OCA-B expression plasmid (10 Ag) was also co-transfected in select studies evaluating Oct-2 effects on HIV-1 transcription. After electroporation and 2 h rest at 37 jC, CD4 T cells were stimulated in vitro with PMA (25 ng/ml) and ionomycin (1.5 AM) for 6 h at 37 jC. Cell lysates were generated with Passive Lysis Buffer (Promega) as previously described (Cron et al., 1999) . Firefly luciferase reporter activity was determined in duplicate and corrected for transfection efficiency based on Renilla luciferase activity (Dual Luciferase Assay Kit, Promega) using a Lumat LB 9507 luminometer (EE and G Berthold, Bad Wildbad, Germany) as previously detailed (Behre et al., 1999; Cron et al., 2000) .
Transient overexpression of Oct proteins in primary human CD4 T cells
Primary human CD4 T cells were transfected with a mixture of plasmid DNA by a novel electroporation-based technology, Amaxa Nucleofector (Koln, Germany), as previously described (Cron, 2003; Lenz et al., 2003) . We previously determined the optimal ratio of pEGFP-N1 to pCG-based Oct expression plasmids to be 1:5 to maximize dual expression of the plasmids (data not shown). For each Amaxa nucleotransfection reaction, 6 million primary CD4 T cells were incubated with 2.4 Ag of total plasmid DNA. After transfection and 2 h rest at 37 jC, the cells were cultured in complete medium (CM) (Cron et al., 1999) supplemented with PHA (2.0 Ag/ml) and IL-2 (20 U/ml) at 37 jC in humidified 5% CO 2 for 2 days to allow for HIV-1 infection.
HIV-1 infection of CD4 T cells
CD4 T cells were transfected with GFP-and Oct-expression plasmids and were cultured as above. The cells were infected 2 days later with the NL4-3 strain of HIV-1 at a multiplicity of infection (MOI) of 0.1 as previously detailed (Selliah and Finkel, 2001b) . The cells were then cultured in CM with 20 U/ml IL-2 at 37 jC in humidified 5% CO 2 for an additional 3 days before analysis.
p24/gag detection
The culture media of infected primary CD4 T cells were replaced completely with fresh media after 2 days of infection. Twenty-four hours later, the culture media were harvested for p24 detection. The cultural supernatants were first diluted 1:100 with media and then assayed in triplicate for p24/gag detection by ELISA, covering a standard range of 7.8 -250 pg/ml. The commercial (Beckman Coulter) ELISA detection method has been described elsewhere (Novick et al., 1996) .
Analysis of apoptosis
Three days after infection, HIV-1-infected (p24 + ) and bystander (p24 À ) CD4 T cells were analyzed by flow cytometry for evidence of apoptosis using 7AAD and Annexin V staining as previously described (Selliah and Finkel, 2001a) . The cells were analyzed using FACSCalibur (Becton Dickinson, San Jose, CA). GFP expression (detected using FITC parameters, FL1) represented Oct overexpressing cells, p24 expression (detected with antip24-Phyco-erythrin, FL2) represented infected cells, and 7AAD bound to DNA (detected using FL3) or Annexin V expression (detected by anti-Annexin V-biotin followed by strepavidin-APC, FL4) represented apoptotic cells. The data were analyzed with CellQuest software (Becton Dickinson) as previously described (Cron et al., 1999) .
Nuclear protein preparation and EMSA
Nuclear proteins from BJA/B cells (kindly provided by Dr. Stephan A. Grupp, University of Pennsylvania, Philadelphia, PA) or from transiently transfected primary human CD4 T cells were extracted as previously described (Schreiber et al., 1989) . Oligonucleotides used as 32 Plabeled probes or as unlabeled competitors are listed in Fig. 1 . Electrophoretic mobility shift assays (EMSAs) were performed as previously described (Dolganov et al., 1996) . In brief, 2 Ag of nuclear protein, 25 000 cpm of 32 P-labeled probe, and EMSA binding buffer (500 mM Tris -HCI, pH 7.5; 500 mM KCL; 15 mM MgCl 2 ; 10 mg/ml BSA; 50% glycerol; 5 mg/ml single strand sperm DNA; 1 mM DTT) were mixed and incubated 20 min on ice. For specificity determinations, nuclear protein was reacted with excess (200-fold) unlabeled probe or 2 Al of Oct-specific antibodies 30 min before the addition of labeled probe. The mixtures were then electrophoresed on 6% gradient pre-poured DNA retardation gels (Novex, San Diego, CA). Radioactive bands were detected by conventional autoradiography.
